Overview

TGIR Randomized Placebo-controlled Healthy Subject Study

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The primary research objective of this study is to confirm the absence of side-effects and explore any analgesic properties of the botanical formulation TGIR (Traditional Gastrointestinal Remedy) in healthy participants.
Phase:
Phase 4
Details
Lead Sponsor:
University of British Columbia
Collaborator:
Resilience Biosciences Inc (RBI)